André Richard da Silva Oliveira Filho

André Richard da Silva Oliveira Filho

Auto-generated profile, based on publicly available information

André Richard da Silva Oliveira Filho

Universidade Federal da Paraíba, João Pessoa, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2024 in Journal of Orthopaedics
Verified
Journal Article
Closed access
RCRodrigo Arruda Conde
Rodrigo Arruda Conde
AFAndré Richard da Silva Oliveira Filho
André Richard da Silva Oliveira Filho
EMElcio Machinski
Elcio Machinski
VCVinícius Furtado da Cruz
Vinícius Furtado da Cruz
BVBruno Butturi Varone
Bruno Butturi Varone
DLDaniel Peixoto Leal
Daniel Peixoto Leal

21 January 2026 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
RCRodrigo Bernstein Conde
Rodrigo Bernstein Conde
AFAndré Richard da Silva Oliveira Filho
André Richard da Silva Oliveira Filho
EMElcio Machinski
Elcio Machinski
VCVinícius Furtado da Cruz
Vinícius Furtado da Cruz
BVBruno Butturi Varone
Bruno Butturi Varone
DLDaniel Peixoto Leal
Daniel Peixoto Leal
Background: Anterior cruciate ligament reconstruction with suture augmentation (ACLR-SA) has been explored for its potential to provide additional graft protection. Purpose: To compare failure rates, complications, patient-reported outcomes, and return to sport between ACLR-SA and nonaugmented ACLR. Study Design: Systematic review and meta-analysis; Level of evidence, 2. Methods: Randomized controlled trials and quasi-experimental studies were included if they provided data on population (patients with anterior cruciate ligament tear), intervention (ACLR-SA regardless of SA material and graft type), comparator (nonaugmented ACLR), and outcomes (failure, arthrofibrosis and cyclops, subsequent meniscal surgery, hardware removal, Lysholm and International Knee Documentation Committee scores, and/or return to sport). Results: Eleven articles (1179 patients) were included. ACLR performed with hamstring autograft augmented with FiberTape reduced failure rates as compared with nonaugmented ACLR (3.1% vs 8.5%; odds ratio [OR], 2.86; 95% CI, 1.03-7.90; P = .043; I 2 = 0%). In addition, the 2 techniques showed no differences in arthrofibrosis/cyclops (OR, 0.94; 95% CI, 0.26-3.33; P = .919; I 2 = 0%), subsequent meniscal surgery (OR, 1.05; 95% CI, 0.32-3.44; P = .942; I 2 = 0%), International Knee Documentation Committee score (mean difference, –1.20; 95% CI, –3.06 to 0.06; P = .206; I 2 = 0%), and Lysholm score (mean difference, –0.96; 95% CI, –4.53 to 2.61; P = .597; I 2 = 65%). When the FiberWire was utilized for hamstring autograft suture augmentation, no significant differences in failure rates were observed between groups. The pooled synthesis for all graft and augmentation combinations showed that ACLR-SA was associated with an increased return to preinjury activity level (72.5% vs 54.0%; OR, 0.44; 95% CI, 0.21-0.91; P = .027; I 2 = 0%). Conclusion: Available evidence supports the use of suture tape augmentation in ACLRs performed with hamstring autografts, as it reduces failure rates while maintaining equivalent complication rates and patient-reported outcomes as compared with nonaugmented ACLR.

1 January 2026 in Acta Ortopedica Brasileira
Verified
Journal Article
Open access
AFAndre Richard da Silva Oliveira Filho
Andre Richard da Silva Oliveira Filho
RCRodrigo Bernstein Conde
Rodrigo Bernstein Conde
EMElcio Machinski
Elcio Machinski
VCVinicius Furtado da Cruz
Vinicius Furtado da Cruz
CHCamilo Partezani Helito
Camilo Partezani Helito
DLDaniel Peixoto Leal
Daniel Peixoto Leal
Objective: Early postoperative rehabilitation is essential for optimal outcomes after total knee arthroplasty (TKA). Femoral nerve block and local infiltration analgesia (LIA) are commonly used for postoperative pain control. However, the relative efficacy of single-shot femoral nerve block (sFNB) versus LIA remains uncertain. This meta-analysis compared both strategies in patients undergoing TKA. Methods: Medline, Cochrane Library, and Embase databases were searched for randomized controlled trials (RCTs) comparing sFNB and LIA in TKA patients. Outcomes included postoperative pain scores, opioid consumption, range of motion (ROM), and length of hospital stay. Results: Of 922 studies identified, 11 RCTs comprising 1,109 patients were included. No significant differences were observed between groups regarding early postoperative pain scores (mean difference [MD] = 0.25 points; 95% confidence interval [CI]: −0.19 to 0.69) or opioid consumption (MD = 0.55 mg; 95% CI: −3.28 to 4.38). However, the LIA group demonstrated improved ROM on postoperative day 2 (MD = −6.15 degrees; 95% CI: −9.16 to −3.14) and shorter hospital stay (MD = 0.23 days; 95% CI: 0.06 to 0.41). Conclusions: LIA was associated with improved ROM on the second postoperative day and shorter hospital stay compared with sFNB, without significant differences in pain scores or opioid consumption. Level of Evidence II; Systematic review and meta-analysis of randomized clinical trials.

5 July 2025 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
LBLucas Cael Azevedo Ramos Bendaham
Lucas Cael Azevedo Ramos Bendaham
ANAltair Pereira de Melo Neto
Altair Pereira de Melo Neto
HFHilária Saugo Faria
Hilária Saugo Faria
AFAndré Richard da Silva Oliveira Filho
André Richard da Silva Oliveira Filho
CFCarlos Henrique de Oliveira Ferreira
Carlos Henrique de Oliveira Ferreira
FMFabrício Tavares Mendonça
Fabrício Tavares Mendonça
Tracheal extubation after general anesthesia may cause hemodynamic and respiratory complications, with no established strategies to prevent them. We conducted a meta-analysis to evaluate the safety and efficacy of beta-blockers in patients undergoing tracheal extubation. We searched the MEDLINE, EMBASE and CENTRAL databases for randomized controlled trials up to 2024 comparing beta-blockers to placebo in patients undergoing tracheal extubation. cough intensity; secondary: bronchospasm, bucking, hypertension. Risk Ratios (RR) with 95% Confidence Intervals (95% CI) were computed. Leave-one-out sensitivity and meta-regression analyses were performed for outcomes with high heterogeneity. We included 31 randomized studies, comprising 1,803 patients, of whom 965 received beta-blockers. The risk of moderate/severe cough (RR = 0.21; 95% CI 0.13 to 0.34; p < 0.001; I2 = 0%) and hypertension (RR = 0.28; 95% CI 0.13 to 0.58; p < 0.001; I2 = 45%) was significantly lower in the beta-blockers group compared with the placebo group. There were no statistically significant differences between groups in the risk of bronchospasm (RR = 0.58; 95% CI 0.17 to 1.94; p = 0.375; I2 = 0%) or bucking (RR = 0.47; 95% CI 0.20 to 1.13; p = 0.093; I2 = 72%). Sensitivity analysis identified Mendonça (2023) as the main heterogeneity source in bucking. Our study demonstrates that beta-blockers reduced moderate/severe cough and hypertension in patients undergoing tracheal extubation compared with placebo with no significant difference in the risk of bronchospasm and bucking. These findings suggest beta-blockers may be a valuable strategy for preventing peri-extubation hemodynamic instability and airway hyperresponsiveness. CRD42024542103.